Clinical Trials Directory

Trials / Completed

CompletedNCT04146259

Changes in Circulating Sclerostin Levels During Acute Postsurgical Hypoparathyroidism

Status
Completed
Phase
Study type
Observational
Enrollment
109 (actual)
Sponsor
University of Athens · Academic / Other
Sex
Female
Age
19 Years
Healthy volunteers
Not accepted

Summary

To investigate changes in sclerostin levels following acute post-thyroidectomy hypoparathyroidism

Detailed description

Female patients with thyroid disorders, referred to the Department of Head and Neck Surgery, at Metaxa Anti-Cancer Hospital of Piraeus, for total thyroidectomy. Based on the development of biochemical hypocalcemia (cCa \< 8.4 mg/dl), subjects were divided into 2 groups: Group A: without postsurgical hypoparathyroidism that served as controls and group B: subjects, with acute postsurgical hypoparathyroidism. Blood collections were performed in the morning after an overnight fast, in at least 3 different time points; preoperatively, 1st postoperative day and 7th postoperative day for the detrmination of sclerostin levels

Conditions

Interventions

TypeNameDescription
DRUGcalcium carbonate and alphacalcidoltreatment for hypocalcemia

Timeline

Start date
2017-01-01
Primary completion
2018-12-31
Completion
2019-08-01
First posted
2019-10-31
Last updated
2019-11-01

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT04146259. Inclusion in this directory is not an endorsement.

Changes in Circulating Sclerostin Levels During Acute Postsurgical Hypoparathyroidism (NCT04146259) · Clinical Trials Directory